
    
      A single-center, randomized, open-label, 12 months study, with two parallel group to compare
      the efficacy of everolimus combination + tacrolimus in regression of left ventricular
      hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the
      maintenance phase.
    
  